NCT02920749 - Study of Anaesthesia Costs and Recovery Profiles | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions

Anaesthesia

Interventions

DRUG

Sevoflurane group A

In this group anaesthesia was maintained with sevoflurane. Initial and maintenance fresh gas flow was 4 and 1 l/min, respectively. Sevoflurane dosing was adjusted for the same MAP range.

DRUG

Sevoflurane group B

In this group anaesthesia was maintained with sevoflurane. Initial and maintenance fresh gas flow was 4 and 1 l/min, respectively. Sevoflurane dosing was set to maintain target BIS levels of 40 to 60 and MAP for controlled hypotension within 60-85 mmHg.

DRUG

Propofol group C

In this group anaesthesia was maintained with propofol. Propofol was administered according to protocol. Propofol dosing was adjusted for the same MAP range.

DRUG

Propofol group D

In this group anaesthesia was maintained with propofol. Propofol dosing was set to maintain target BIS levels of 40 to 60 and MAP for controlled hypotension within 60-85 mmHg.

Trial Locations (1)

7624

Tímea Bocskai, Pécs

All Listed Sponsors

lead

University of Pecs

OTHER